General Information of the Compound
| Compound ID |
CP0856438
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-2-(4-Fluorophenyl)-N-(4-(((2S,5R)-5-((R)-hydroxy(pyridin-3-yl)methyl)pyrrolidin-2-yl)methyl)phenyl)-5,6-dihydro-4Hcyclopenta[d]thiazole-4-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H29FN4O2S
|
||||||||||||||||||
| Molecular Weight |
528.653
|
||||||||||||||||||
| Canonical SMILES |
O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3cccnc3)N2)cc1)[C@@H]1CCc2sc(-c3ccc(F)cc3)nc21
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H29FN4O2S/c31-21-7-5-19(6-8-21)30-35-27-24(12-14-26(27)38-30)29(37)34-22-9-3-18(4-10-22)16-23-11-13-25(33-23)28(36)20-2-1-15-32-17-20/h1-10,15,17,23-25,28,33,36H,11-14,16H2,(H,34,37)/t23-,24+,25+,28+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
AHGPIPADZZLPDD-XVOBZGQLSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor